학술논문
Infliximab and Tofacitinib Attenuate Neutralizing Antibody Responses Against SARS-CoV-2 Ancestral and Omicron Variants in Inflammatory Bowel Disease Patients After 3 Doses of COVID-19 Vaccine
Document Type
Short Survey
Author
Le, Kaixing; Zhou, Xin; Ibraheim, Hajir; Anandabaskaran, Sulak; Saifuddin, Aamir; McFarlane, Leon R.; Anand, Nikhil; Constable, Laura; Seoane, Rocio Castro; D’Mello, Andrea; Balarajah, Sharmili; Hicks, Lucy C.; Williams, Horace R.T.; Lo, Jonathan W.; Hart, Ailsa L.; Altmann, Daniel M.; Boyton, Rosemary J.; Teare, Julian P.; Nice, Rachel; Bewshea, Claire; Goodhand, James R.; Kennedy, Nicholas A.; Barnes, Anna; Kirkwood, John; Parkinson, Marian; Gardner-Thorpe, Helen; Lees, Charlie W.; Jones, Gareth R.; Covil, Kate; Derikx, Lauranne; Fiorentino, Francesca; Irving, Peter M.; Parkes, Miles; Linger, Rachel; Kok, Klaartje; Lee, Irish; Cipriano, Bessie; Patel, Kamal V.; Sebastian, Shaji; Kent, Alexandra J.; Chukwurah, Ijeoma; Haq, Sulaimaan; Shah, Parita; Wilken-Smith, Stephanie; Ramanathan, Anitha; Patel, Mikin; Romanczuk, Lidia; King, Rebecca; Domingo, Jason; Knight, Bridget; Shamtally, Djamila; Mendoza, Vivien; Sanchez, Joanne; Stark, Hannah; Bee, Louise; Estember, Charmaine; Watkins, Darcy; Stone, Sam; Alcalde, Beatriz Gros; Ruocco, Giuseppe; Baden, Manisha; Cooke, Graham; Kourampa, Evgenia; Pasquale, Ciro; Robisco-Diaz, Elena; Bhatti, Suhaylah; Liu, Zhigang; Alexander, James L.; Lin, Kathy Weitung; Ahmad, Tariq; Pollock, Katrina M.; Powell, Nick
Source
In Gastroenterology February 2023 164(2):300-303
Subject
Language
ISSN
0016-5085